Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Feisal A Al-Kassimi & Esam H Alhamad. (2013) A challenge to the seven widely believed concepts of COPD. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 21-30.
Read now
Read now
Jan Willem H Kocks, Jan Willem K van den Berg, Huib AM Kerstjens, Steven M Uil, Judith M Vonk, Ynze P de Jong, Ioanna G Tsiligianni & Thys van der Molen. (2013) Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 273-286.
Read now
Read now
Victoria Beasley, Priya V Joshi, Aran Singanayagam, Philip L Molyneaux, Sebastian L Johnston & Patrick Mallia. (2012) Lung microbiology and exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 555-569.
Read now
Read now
Eef D Telenga, Huib AM Kerstjens, Dirkje S Postma, Nick H ten Hacken & Maarten van den Berge. (2010) Inhaled corticosteroids in chronic obstructive pulmonary disease: a review. Expert Opinion on Pharmacotherapy 11:3, pages 405-421.
Read now
Read now
Erik Bathoorn, Jeroen JW Liesker, Dirkje S Postma, Gerard H Koëter, Marco van der Toorn, Sicco van der Heide, H Alec Ross, Antoon JM van Oosterhout & Huib AM Kerstjens. (2009) Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 4, pages 101-109.
Read now
Read now
Articles from other publishers (23)
Jean-Laurent Thebault, Nicolas Roche, Hendy Abdoul, Alain Lorenzo, Thomas Similowski & Christian Ghasarossian. (2023) Efficacy and safety of oral corticosteroids to treat outpatients with acute exacerbations of COPD in primary care: a multicentre pragmatic randomised controlled study. ERJ Open Research 9:5, pages 00057-2023.
Crossref
Crossref
Francesco NUCERA, Sharon MUMBY, Keshav R. PAUDEL, Vivek DHARWAL, Antonino DI STEFANO, Vincenzo CASOLARO, Philip M. HANSBRO, Ian M. ADCOCK & Gaetano CARAMORI. (2022) Role of oxidative stress in the pathogenesis of COPD. Minerva Medica 113:3.
Crossref
Crossref
Krishna Sriram, Michael B. Insel & Paul A. Insel. (2022)
Inhaled
β
2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?
. Pharmacological Reviews 73:4, pages 1659-1697.
Crossref
Crossref
Benedikt Ditz, Aartik Sarma, Huib A.M. Kerstjens, Jeroen J.W. Liesker, Erik Bathoorn, Judith M. Vonk, Victor Bernal, Peter Horvatovich, Victor Guryev, Saharai Caldera, Chaz Langelier, Alen Faiz, Stephanie A. Christenson & Maarten van den Berge. (2021) The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils. ERJ Open Research 7:3, pages 00097-2021.
Crossref
Crossref
Botond Szucs, Csilla Szucs, Mate Petrekanits & Janos T. Varga. (2019) Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article. International Journal of Molecular Sciences 20:18, pages 4329.
Crossref
Crossref
Kurt Brassington, Stavros Selemidis, Steven Bozinovski & Ross Vlahos. (2019) New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clinical Science 133:7, pages 885-904.
Crossref
Crossref
Štefan Laššán, Marta Hájková & Monika Laššánová. (2017) Anti-inflammatory treatment of stable COPD - current trends and recommendations for clinical practiceExperts statement. Klinická farmakologie a farmacie 31:1, pages 22-30.
Crossref
Crossref
Jadwiga A. Wedzicha(ERS co-ch(ERS co-ch, Marc Miravitlles, John R. Hurst, Peter M.A. Calverley, Richard K. Albert, Antonio Anzueto, Gerard J. Criner, Alberto Papi, Klaus F. Rabe, David Rigau, Pawel Sliwinski, Thomy Tonia, Jørgen Vestbo, Kevin C. Wilson & Jerry A. Krishnan(ATS co-ch(ATS co-ch. (2017) Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. European Respiratory Journal 49:3, pages 1600791.
Crossref
Crossref
Štefan Laššán, Monika Laššánová, Jana Tisoňová & Peter Krištúfek. (2016) Summary. Klinická farmakologie a farmacie 30:1, pages 22-29.
Crossref
Crossref
M. Grobman & C. Reinero. (2016) Investigation of Neurokinin‐1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs. Journal of Veterinary Internal Medicine 30:3, pages 847-852.
Crossref
Crossref
Simon D. Pouwels, Martijn C. Nawijn, Erik Bathoorn, Annelies Riezebos-Brilman, Antoon J.M. van Oosterhout, Huib A.M. Kerstjens & Irene H. Heijink. (2015) Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients. European Respiratory Journal 45:5, pages 1482-1485.
Crossref
Crossref
Wenhui Zhang, Jianming Zhi, Yongyao Cui, Fan Zhang, Ad?lite Habyarimana, Carole Cambier & Pascal Gustin. (2014) Potentiated Interaction between Ineffective Doses of Budesonide and Formoterol to Control the Inhaled Cadmium-Induced Up-Regulation of Metalloproteinases and Acute Pulmonary Inflammation in Rats. PLoS ONE 9:10, pages e109136.
Crossref
Crossref
K. Suresh Babu, Jack A. Kastelik & Jaymin B. Morjaria. (2014) Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. British Journal of Clinical Pharmacology 78:2, pages 282-300.
Crossref
Crossref
Paul T King, Martin MacDonald & Philip G Bardin. (2013) Bacteria in COPD; their potential role and treatment. Translational Respiratory Medicine 1:1.
Crossref
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes & Rebecca Normansell. (2013)
Combined corticosteroid and long-acting beta
2
-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews 2018:3.
Crossref
Crossref
Rubaiyat Haque, Amir Hakim, Thunicia Moodley, Alfonso Torrego, Sarah Essilfie-Quaye, Elen Jazrawi, Malcolm Johnson, Peter J. Barnes, Ian M. Adcock & Omar Sharif Usmani. (2013) Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD. Journal of Allergy and Clinical Immunology 132:5, pages 1166-1173.
Crossref
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan & Annabel Kesterton. (2013)
Combined corticosteroid and long-acting beta
2
-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews 2014:6.
Crossref
Crossref
Angela Koutsokera, Konstantinos Kostikas, Laurent P Nicod & Jean-William Fitting. (2013) Pulmonary biomarkers in COPD exacerbations: a systematic review. Respiratory Research 14:1, pages 111.
Crossref
Crossref
Marianne de Vries, Annette J Berendsen, Henk EP Bosveld, Huib AM Kerstjens & Thys van der Molen. (2012) COPD exacerbations in general practice: variability in oral prednisolone courses. BMC Family Practice 13:1.
Crossref
Crossref
Lesley J. Scott. (2012) Budesonide/Formoterol Turbuhaler®. Drugs 72:3, pages 395-414.
Crossref
Crossref
Jeroen J.W. Liesker, Erik Bathoorn, Dirkje S. Postma, Judith M. Vonk, Wim Timens & Huib A.M. Kerstjens. (2011) Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respiratory Medicine 105:12, pages 1853-1860.
Crossref
Crossref
. (2010) Defining the role of exhaled nitric oxide measurements in COPD. Respirology 15:3, pages 385-386.
Crossref
Crossref
T. Welte. (2009) Optimising treatment for COPD - new strategies for combination therapy. International Journal of Clinical Practice 63:8, pages 1136-1149.
Crossref
Crossref